Truqap is actually a kinase inhibitor that works by blocking pathways that assist the cancer cells endure and grow, so minimizes cancer growth. Truqap is from a category of medicines called an AKT inhibitor. Truqap gained FDA approval on November 17, 2023, following optimistic success from the CAPItello-291 Section III https://zidebactam79023.elbloglibre.com/34727772/everything-about-venetoclax